487 related articles for article (PubMed ID: 22124885)
1. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
3. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
4. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
Slowing I; Trewyn BG; Lin VS
J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
[TBL] [Abstract][Full Text] [Related]
5. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
6. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
7. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
[TBL] [Abstract][Full Text] [Related]
8. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
[TBL] [Abstract][Full Text] [Related]
9. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.
Huang X; Teng X; Chen D; Tang F; He J
Biomaterials; 2010 Jan; 31(3):438-48. PubMed ID: 19800115
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
11. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
[TBL] [Abstract][Full Text] [Related]
12. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
13. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
He Q; Zhang J; Shi J; Zhu Z; Zhang L; Bu W; Guo L; Chen Y
Biomaterials; 2010 Feb; 31(6):1085-92. PubMed ID: 19880176
[TBL] [Abstract][Full Text] [Related]
14. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
16. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
Roggers RA; Lin VS; Trewyn BG
Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
[TBL] [Abstract][Full Text] [Related]
17. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
18. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
He Q; Zhang Z; Gao F; Li Y; Shi J
Small; 2011 Jan; 7(2):271-80. PubMed ID: 21213393
[TBL] [Abstract][Full Text] [Related]
19. Sub-150 nm mesoporous silica nanoparticles with tunable pore sizes and well-ordered mesostructure for protein encapsulation.
Gu J; Huang K; Zhu X; Li Y; Wei J; Zhao W; Liu C; Shi J
J Colloid Interface Sci; 2013 Oct; 407():236-42. PubMed ID: 23866201
[TBL] [Abstract][Full Text] [Related]
20. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
Du X; Xiong L; Dai S; Qiao SZ
Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
